Celebrating 13 Years of Nonprofit Independence
Menu
Shedding Light on the Risks
& Benefits of Medications 
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Menu
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Eye Health

Tyrvaya … A Nasal Spray for Dry Eyes?

The Food and Drug Administration (FDA) approved Tyrvaya, a new nasal spray designed to treat dry eye disease, in October 2021. A major benefit of the new drug is that it won’t require patients to…

Dec 14, 2021

5 Drugs That Can Cause Dry Eye Disease

Dry eye disease is irritating and painful. As an optometrist, I know there are many possible causes, but thedrugs you take might be the culprit.

May 27, 2020
RECOMMENDED:
FDA SIDE EFFECTS UPDATE: Migraine Drug Constipation Risk, Boxed Warning Update for Methotrexate
FDA SIDE EFFECTS UPDATE: Migraine Drug Constipation Risk, Boxed Warning Update for Methotrexate
Read More
FDA SIDE EFFECTS UPDATE: Blood Pressure Drug Linked to Life-Threatening Swelling, Black Box Updates for Gastroparesis Meds
FDA SIDE EFFECTS UPDATE: Blood Pressure Drug Linked to Life-Threatening Swelling, Black Box Updates for Gastroparesis Meds
Read More
FDA SIDE EFFECTS UPDATE: Antidepressants, Stimulants May Interfere With Parkinson’s Test
FDA SIDE EFFECTS UPDATE: Antidepressants, Stimulants May Interfere With Parkinson’s Test
Read More

What is unbiased drug-safety journalism worth to you?

We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.

Donate to MedShadow
trigger

What is Unbiased Drug-Safety Journalism Worth to You?

We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.

As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.

trigger